ReviewCPT: pharmacometrics & systems pharmacology2021

End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitor.

Daryl J Fediuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.